Article

Body size, dose of hemodialysis, and mortality

US Renal Data System Coordinating Center, University of Michigan, Ann Arbor, MI, USA.
American Journal of Kidney Diseases (Impact Factor: 5.76). 01/2000; 35(1):80-8. DOI: 10.1016/S0272-6386(00)70305-2
Source: PubMed

ABSTRACT This study investigates the role of body size on the mortality risk associated with dialysis dose in chronic hemodialysis patients. A national US random sample from the US Renal Data System was used for this observational longitudinal study of 2-year mortality. Prevalent hemodialysis patients treated between 1990 and 1995 were included (n = 9,165). A Cox proportional hazards model, adjusting for patient characteristics, was used to calculate the relative risk (RR) for mortality. Both dialysis dose (equilibrated Kt/V [eKt/V]) and body size (body weight, body volume, and body mass index) were independently and significantly (P < 0.01 for each measure) inversely related to mortality when adjusted for age and diabetes. Mortality was less among larger patients and those receiving greater eKt/V. The overall association of mortality risk with eKt/V was negative and significant in all patient subgroups defined by body size and by race-sex categories in the range 0.6 < eKt/V < 1.6. The association was negative in the restricted range 0.9 < eKt/V < 1.6 (although not generally significant) for all body-size subgroups and for three of four race-by-sex subgroups, excepting black men (RR = 1. 003/0.1 eKt/V; P > 0.95). These findings suggest that dose of dialysis and several measures of body size are important and independent correlates of mortality. These results suggest that patient management protocols should attempt to ensure both good patient nutrition and adequate dose of dialysis, in addition to managing coexisting medical conditions.

0 Followers
 · 
127 Views
 · 
0 Downloads
  • Source
    • "t 5 Higher mortality with lower BMI Fleischmann et al . , 1999 ( 78 ) US , multicenter 1346 Prevalent 1 Higher mortality with lower BMI ; lower death risk among overweight / obese Kopple et al . , 1999 ( 79 ) Fresenius US 12 , 965 Prevalent 1 Progressive decrease in mortality with increasing weight - for - height with lowest risk in obese patients Wolfe et al . , 2000 ( 80 )"
    [Show abstract] [Hide abstract]
    ABSTRACT: In the past decade, peritoneal dialysis use among patients with end-stage renal disease has declined in many countries. Studies from the United States indicate that many academic centers do not have adequate resources to train fellows, most incident dialysis patients are not offered peritoneal dialysis, and more than half of dialysis clinics do not have the infrastructure to support peritoneal dialysis. Some are concerned that the outcomes of peritoneal dialysis and maintenance hemodialysis patients may not be equivalent, a notion that is not supported by outcome studies. Given the effect of modality selection on patients' lifestyle, attempts to conduct a randomized, controlled comparison of maintenance hemodialysis and peritoneal dialysis have been unsuccessful. Most observational studies showed that peritoneal dialysis is associated with a survival advantage that diminishes over time; it is unclear whether any of the differences over time are attributable to the modality. Between 1996 and 2003, the early outcomes of peritoneal dialysis patients further improved, whereas those for maintenance hemodialysis patients remained unchanged. Differences in outcomes may be due to residual statistical confounding; however, several biologic mechanisms can be postulated: The early survival advantage may be related to the better preservation of residual renal function with peritoneal dialysis, and the diminution of the survival advantage may be related to worsened volume control. There is a need for large observational and interventional studies among peritoneal dialysis patients to sustain and enforce the improvements in both dialysis therapies.
    Clinical Journal of the American Society of Nephrology 12/2007; 2(6):1317-28. DOI:10.2215/CJN.02550607 · 5.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Higher than normal body mass index (BMI) is associated with an increased risk of death in the general population. We examined the effect of higher than normal BMI on patient and technique survival in peritoneal dialysis patients (PD), controlling for comorbidity, initial albumin, dialysate-to-plasma ratio of creatinine (D/P(Cr)), and initial urea clearance (Kt/V). Registry database. Four dialysis centers. Incident PD patients. All data were collected prospectively. Demographics, BMI, serum albumin, D/P(Cr), and comorbidity using the Charlson Comorbidity Index (CCI) were determined at the start of PD. 104 patients with a high BMI (> 27) were matched to a control group of 104 patients with normal BMI (20-27) for age, gender, presence of diabetes, and CCI. Patient and technique survival were compared using Cox proportional hazards model. Patient and technique survival. The groups were of similar age (56.1 vs 56.7 years), sex (60% males in both groups), race (Caucasian 80% vs 86%), presence of diabetes (40% vs 37%), CCI score (5.4 in both groups), initial albumin (3.6 vs 3.5 g/dL), and D/P(Cr) (0.65 in both groups). Kaplan-Meier survival analysis showed similar 2-year patient survival between large BMI (> 27) and control (20-27) groups (76.6% vs 76.1%). Two-year technique survival was also similar between the two groups (59.7% vs 66.8%). With Cox proportional hazards analysis, BMI was not a predictor of patient mortality or technique survival when controlling for initial albumin, D/P(Cr), and initial Kt/V. We conclude that a BMI above normal is not associated with any increased or decreased risk of death in patients on PD for 2 years.
    Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis 01/2002; 22(2):191-6. · 2.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: INTRODUCCIÓN En las dos últimas décadas se puesto de manifiesto la necesidad de disminuir la variabilidad de la prácti-ca clínica y adaptarla al grado de conocimiento cien-tífico existente en cada momento. La consecuencia inmediata de este estado de opinión fue la aparición de las Guías Clínicas basadas en la evidencia. La publicación en 1997 de la primera Guía Clínica KDOQI causó un gran impacto en la comunidad ne-frológica y fue seguida de la presentación de Guías similares en otros países. Las Guías Clínicas no solo constituyen una herramienta fundamental para ho-mogeneizar el tratamiento de la insuficiencia renal crónica, sino que han servido para resaltar la gran im-portancia que tiene el conocimiento del grado de evi-dencia científica que respalda cada una de las actua-ciones que realizamos en la práctica cotidiana. En el presente capítulo revisamos el nivel de evi-dencia existente en los diferentes tópicos relaciona-dos con el tratamiento con hemodiálisis crónica. LA INICIACIÓN DE LA HEMODIÁLISIS CRÓNICA La cifra de filtrado glomerular a la que se debe co-menzar el tratamiento con hemodiálisis no está defi-nida. No hay ensayos controlados y aleatorizados que traten este tópico. La Guía Europea de Buena Práctica en Hemodiálisis 1 recomienda el inicio del tratamiento sustitutivo cuando el filtrado glomerular sea inferior a 15 ml/min/1,73 m 2 y haya datos clínicos de desnutrición, sobrecarga de volumen sin respuesta a diuréticos u otros síntomas o signos atribuidos a uremia. En el enfermo asintomático, las Guías Clíni-cas Europea, Canadiense y Australiana 1-3 aconsejan iniciar el tratamiento con diálisis cuando el filtrado glomerular sea de 6 ml/min/1,73 m 2 (Evidencia C). En estos momentos se está realizando un ensayo clínico para valorar las posibles ventajas del inicio precoz del tratamiento sustitutivo en enfermos asinto-máticos. Este ensayo concluirá en el año 2008 4 . Mientras tanto parece prudente seguir las indicacio-nes de las Guías Clínicas anteriormente citadas.
Show more